New product launches on track and revenue continues to show growth, excluding Lexapro (US)
2 May 2012 | By H. Lundbeck A/S
H. Lundbeck A/S reports first quarter revenue of DKK 3,442 million...
List view / Grid view
2 May 2012 | By H. Lundbeck A/S
H. Lundbeck A/S reports first quarter revenue of DKK 3,442 million...
2 May 2012 | By Syrris
Syrris is building on the success of its previous flow chemistry and automated process chemistry seminars...
2 May 2012 | By Citigate Dewe Rogerson
Dr Esteban Pombo-Villar appointed as COO of the OBT group...
1 May 2012 | By Novartis
Results from two-year CATT...
1 May 2012 | By GlaxoSmithKline
GSK and Yale University have established a drug discovery research collaboration...
1 May 2012 | By Catalent Pharma Solutions
Carolyn Finkle at Catalent to present webinar...
1 May 2012 | By Pall Life Sciences
Pall Corporation will introduce five new single-use products at INTERPHEX 2012...
1 May 2012 | By Pfizer
The U.S. FDA has approved ELELYSO™...
1 May 2012 | By Gilead Sciences
Gilead Sciences announced that the first patient has been dosed in a Phase 3 clinical trial...
30 April 2012 | By Teva Pharmaceutical Industries Ltd
TEVA, has settled patent infringement litigation with Mylan Inc.'s ANDA for Teva’s wakefulness product NUVIGIL® (armodafinil) tablets...
30 April 2012 | By
BASF will transfer the pharmaceutical production of KolliphorTM TPGS to its Minden facility...
30 April 2012 | By Citigate Dewe Rogerson
Algeta ASA announces that its research collaboration with Sanofi has been extended...
29 April 2012 | By Boehringer Ingelheim
New data on TWYNSTA®...
27 April 2012 | By kdm communications limited
Syrris offers the unique Asia Chip Climate Controller module for its revolutionary range...
27 April 2012 | By Sanofi
Approval of IMOVAX® POLIO by Japanese health authorities...